000 | 01391 a2200361 4500 | ||
---|---|---|---|
005 | 20250513190624.0 | ||
264 | 0 | _c19991229 | |
008 | 199912s 0 0 eng d | ||
022 | _a0006-3223 | ||
024 | 7 |
_a10.1016/s0006-3223(99)00070-0 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKinkead, B | |
245 | 0 | 0 |
_aDoes neurotensin mediate the effects of antipsychotic drugs? _h[electronic resource] |
260 |
_bBiological psychiatry _cAug 1999 |
||
300 |
_a340-51 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
650 | 0 | 4 |
_aBasal Ganglia Diseases _xchemically induced |
650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
650 | 0 | 4 |
_aDopamine _xmetabolism |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 |
_aNeurotensin _xmetabolism |
650 | 0 | 4 |
_aNucleus Accumbens _xdrug effects |
650 | 0 | 4 |
_aRNA, Messenger _xdrug effects |
650 | 0 | 4 |
_aReceptors, Neurotensin _xdrug effects |
650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
700 | 1 | _aBinder, E B | |
700 | 1 | _aNemeroff, C B | |
773 | 0 |
_tBiological psychiatry _gvol. 46 _gno. 3 _gp. 340-51 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0006-3223(99)00070-0 _zAvailable from publisher's website |
999 |
_c10392969 _d10392969 |